Jun 13, 2019 8:00am EDT Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference
Jun 10, 2019 8:00am EDT Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization
May 21, 2019 9:00am EDT Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy
Apr 25, 2019 8:58am EDT Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
Apr 24, 2019 8:00am EDT Eminent M.I.T. Institute Professor, Robert S. Langer, Sc.D., Joins Avalon GloboCare's Scientific and Clinical Advisory Board
Apr 17, 2019 8:00am EDT Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019
Apr 08, 2019 8:35am EDT Avalon GloboCare Appoints Finance Veteran Yue ''Charles'' Li to the Board of Directors
Mar 06, 2019 8:00am EST Avalon GloboCare to Present at the 31st Annual ROTH Conference on March 17-19, 2019
Feb 26, 2019 8:00am EST Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy
Feb 11, 2019 8:30am EST Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells